Header Logo

Connection

BIYKEM BOZKURT to Heart Failure

Back to Details
This is a "connection" page, showing publications BIYKEM BOZKURT has written about Heart Failure.
BIYKEM BOZKURT
Connection Strength
22.285
Heart Failure
  1. Albuminuria as a diagnostic criterion and a therapeutic target in heart failure and other cardiovascular disease. Eur J Heart Fail. 2025 Nov; 27(11):2357-2371.
    View in: PubMed
    Score: 0.359
  2. Cardiac rhythm devices in heart failure with reduced ejection fraction?-?role, timing, and optimal use in contemporary practice. European Journal of Heart Failure expert consensus document. Eur J Heart Fail. 2025 Jul; 27(7):1242-1261.
    View in: PubMed
    Score: 0.356
  3. Compensation Models in?Heart?Failure: Navigating the Complexities for Optimal?Outcomes. JACC Heart Fail. 2024 Aug; 12(8):1500-1504.
    View in: PubMed
    Score: 0.339
  4. Treatment of Obesity in Heart?Failure: The New Era in the Aftermath of the STEP-HFpEF and SELECT Trials. JACC Heart Fail. 2024 Jul; 12(7):1309-1313.
    View in: PubMed
    Score: 0.337
  5. The Year in Review in Heart?Failure. JACC Heart Fail. 2024 Jun; 12(6):1128-1133.
    View in: PubMed
    Score: 0.335
  6. Pre-Heart?Failure, Heart Stress, and Subclinical Heart?Failure: Bridging Heart Health and Heart?Failure. JACC Heart Fail. 2024 Jun; 12(6):1115-1118.
    View in: PubMed
    Score: 0.333
  7. Concerning Trends of Rising Heart?Failure Mortality Rates. JACC Heart Fail. 2024 May; 12(5):970-972.
    View in: PubMed
    Score: 0.333
  8. Contemporary pharmacological treatment and management of heart failure. Nat Rev Cardiol. 2024 08; 21(8):545-555.
    View in: PubMed
    Score: 0.331
  9. Need to Define Severe Heart?Failure: A Subgroup of Stage C Heart?Failure. JACC Heart Fail. 2024 Mar; 12(3):595-598.
    View in: PubMed
    Score: 0.330
  10. Treatment of Clusters of Risks to Prevent Heart?Failure. JACC Heart Fail. 2024 02; 12(2):417-420.
    View in: PubMed
    Score: 0.328
  11. Heart?Failure in Women: Special Issue of JACC: Heart?Failure. JACC Heart Fail. 2023 12; 11(12):1767-1768.
    View in: PubMed
    Score: 0.324
  12. Heart Failure Epidemiology and Outcomes Statistics: A Report of the Heart Failure Society of America. J Card Fail. 2023 10; 29(10):1412-1451.
    View in: PubMed
    Score: 0.320
  13. Heart?Failure in Women: Special Issue in JACC: Heart?Failure. JACC Heart Fail. 2023 09; 11(9):1287.
    View in: PubMed
    Score: 0.318
  14. Pre-Heart?Failure: An Important Opportunity to Prevent a?Deadly?Disease. JACC Heart Fail. 2023 08; 11(8 Pt 1):1027-1031.
    View in: PubMed
    Score: 0.316
  15. Technology and Heart?Failure Therapeutics (THT) Special Issue in JACC: Heart?Failure. JACC Heart Fail. 2023 08; 11(8 Pt 2):1037-1038.
    View in: PubMed
    Score: 0.316
  16. Differentiation Between Worsening Heart?Failure and Decompensated Heart?Failure. JACC Heart Fail. 2023 07; 11(7):859-861.
    View in: PubMed
    Score: 0.315
  17. Mortality, Outcomes, Costs, and Use of?Medicines Following a First Heart?Failure?Hospitalization: EVOLUTION HF. JACC Heart Fail. 2023 10; 11(10):1320-1332.
    View in: PubMed
    Score: 0.314
  18. Nonresponse to Heart?Failure?Therapy: An Important Trajectory. JACC Heart Fail. 2023 06; 11(6):729-732.
    View in: PubMed
    Score: 0.313
  19. Proposed New Conceptualization for Definition of Decompensated?HF: Taking the Acute Out of Decompensation. JACC Heart Fail. 2023 03; 11(3):368-371.
    View in: PubMed
    Score: 0.307
  20. Treatment of Advanced (Stage D) Heart?Failure in the New Era. JACC Heart Fail. 2023 02; 11(2):258-260.
    View in: PubMed
    Score: 0.306
  21. Successful Decongestion as a Clinical Target, Performance Indicator, and as a Study Endpoint in Hospitalized Heart Failure Patients. JACC Heart Fail. 2023 01; 11(1):126-129.
    View in: PubMed
    Score: 0.304
  22. How to Initiate and Uptitrate GDMT in Heart?Failure: Practical Stepwise Approach to Optimization of GDMT. JACC Heart Fail. 2022 12; 10(12):992-995.
    View in: PubMed
    Score: 0.302
  23. What to and Not to Monitor for Uptitration of GDMT in Patients With Heart?Failure: The Case for Patient Self-Uptitration of GDMT. JACC Heart Fail. 2022 11; 10(11):881-884.
    View in: PubMed
    Score: 0.301
  24. Targets for Success in Treatment of Patients Hospitalized for Heart?Failure. JACC Heart Fail. 2022 10; 10(10):782-784.
    View in: PubMed
    Score: 0.299
  25. Heart?Failure Drug Treatment-Inertia,?Titration, and Discontinuation: A Multinational Observational Study (EVOLUTION HF). JACC Heart Fail. 2023 01; 11(1):1-14.
    View in: PubMed
    Score: 0.297
  26. The Need to Stop Inappropriate Coding for Acute Kidney Injury in Heart Failure. JACC Heart Fail. 2022 09; 10(9):692-694.
    View in: PubMed
    Score: 0.297
  27. It Is Time to Screen for Heart?Failure: Why and How? JACC Heart Fail. 2022 08; 10(8):598-600.
    View in: PubMed
    Score: 0.295
  28. JACC: Heart?Failure: A New Vision With the New Editorial Team. JACC Heart Fail. 2022 07; 10(7):525-526.
    View in: PubMed
    Score: 0.294
  29. Telehealth in Heart Failure. Heart Fail Clin. 2022 Apr; 18(2):213-221.
    View in: PubMed
    Score: 0.287
  30. The Emergence of the Heart Failure and Critical Care Medicine Specialist: An Unmet Need That Needs a Rapid Solution. J Card Fail. 2022 02; 28(2):343-345.
    View in: PubMed
    Score: 0.281
  31. Cardiac Rehabilitation for Patients With?Heart?Failure: JACC Expert Panel. J Am Coll Cardiol. 2021 03 23; 77(11):1454-1469.
    View in: PubMed
    Score: 0.269
  32. 2021 ACC/AHA Key Data Elements and Definitions for Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Clinical Data Standards for Heart Failure). Circ Cardiovasc Qual Outcomes. 2021 04; 14(4):e000102.
    View in: PubMed
    Score: 0.269
  33. Universal definition and classification of heart failure: a report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure: Endorsed by the Canadian Heart Failure Society, Heart Failure Association of India, Cardiac Society of Australia and New Zealand, and Chinese Heart Failure Association. Eur J Heart Fail. 2021 03; 23(3):352-380.
    View in: PubMed
    Score: 0.268
  34. 2021 ACC/AHA Key Data Elements and Definitions for Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Clinical Data Standards for Heart Failure). J Am Coll Cardiol. 2021 04 27; 77(16):2053-2150.
    View in: PubMed
    Score: 0.263
  35. Ins and Outs: Perspectives of Inpatient Prescribing for Sacubitril/Valsartan. Ann Pharmacother. 2021 06; 55(6):805-813.
    View in: PubMed
    Score: 0.261
  36. President's Message. J Card Fail. 2020 10; 26(10):905-906.
    View in: PubMed
    Score: 0.260
  37. Joint HFSA/ACC/AHA Statement Addresses Concerns Re: Using RAAS Antagonists in COVID-19. J Card Fail. 2020 05; 26(5):370.
    View in: PubMed
    Score: 0.253
  38. Substance and Substrate: LVEF and Sex Subgroup Analyses of PARAGON-HF and PARADIGM-HF Trials. Circulation. 2020 02 04; 141(5):362-366.
    View in: PubMed
    Score: 0.248
  39. Update in recent clinical trials in heart failure. Curr Opin Cardiol. 2019 07; 34(4):307-314.
    View in: PubMed
    Score: 0.238
  40. Reasons for Lack of Improvement in Treatment With Evidence-Based Therapies in Heart Failure. J Am Coll Cardiol. 2019 05 21; 73(19):2384-2387.
    View in: PubMed
    Score: 0.237
  41. Enkephalins and the Opioid System of the Heart. Circ Heart Fail. 2019 05; 12(5):e005851.
    View in: PubMed
    Score: 0.236
  42. Target Dose Versus Maximum Tolerated Dose in Heart Failure: Time to Calibrate and Define Actionable Goals. JACC Heart Fail. 2019 04; 7(4):359-362.
    View in: PubMed
    Score: 0.234
  43. WORSENING RENAL FUNCTION IN ACUTE DECOMPENSATED HEART FAILURE: A BAD SIGN, OR MAYBE NOT? Trans Am Clin Climatol Assoc. 2019; 130:41-50.
    View in: PubMed
    Score: 0.230
  44. High-Sensitivity Cardiac Troponin: From Patient Phenotypes to Clinical Events in Patients With Heart Failure With Preserved Ejection Fraction. J Am Heart Assoc. 2018 12 18; 7(24):e011174.
    View in: PubMed
    Score: 0.230
  45. What Is New in Heart Failure Management in 2017? Update on ACC/AHA Heart Failure Guidelines. Curr Cardiol Rep. 2018 04 17; 20(6):39.
    View in: PubMed
    Score: 0.219
  46. Heart Failure in Women. Methodist Debakey Cardiovasc J. 2017 Oct-Dec; 13(4):216-223.
    View in: PubMed
    Score: 0.211
  47. Comparison of Frequency of Cardiovascular Events and Mortality in Patients With Heart Failure Using Versus Not Using Cocaine. Am J Cardiol. 2017 06 15; 119(12):2030-2034.
    View in: PubMed
    Score: 0.204
  48. Contributory Risk and Management of Comorbidities of Hypertension, Obesity, Diabetes Mellitus, Hyperlipidemia, and Metabolic Syndrome in Chronic Heart Failure: A Scientific Statement From the American Heart Association. Circulation. 2016 12 06; 134(23):e535-e578.
    View in: PubMed
    Score: 0.198
  49. Usefulness of the Sum of Pulmonary Capillary Wedge Pressure and Right Atrial Pressure as a Congestion Index that Prognosticates Heart Failure Survival (from the Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness Trial). Am J Cardiol. 2016 09 15; 118(6):854-859.
    View in: PubMed
    Score: 0.194
  50. The treatment of heart failure in the 21st century: is the glass half empty or half full? Methodist Debakey Cardiovasc J. 2013 Jan-Mar; 9(1):3-5.
    View in: PubMed
    Score: 0.152
  51. Peripartum cardiomyopathy: a contemporary review. Methodist Debakey Cardiovasc J. 2013 Jan-Mar; 9(1):38-43.
    View in: PubMed
    Score: 0.152
  52. Response to Ryan and Parwani: heart failure patients with low blood pressure: how should we manage neurohormonal blocking drugs? Circ Heart Fail. 2012 Nov; 5(6):820-1.
    View in: PubMed
    Score: 0.150
  53. Echocardiographic changes during treatment of acute decompensated heart failure: insights from the ESCAPE trial. J Card Fail. 2012 Oct; 18(10):792-8.
    View in: PubMed
    Score: 0.149
  54. Worsening renal function is not associated with response to treatment in acute heart failure. Int J Cardiol. 2013 Sep 01; 167(5):1912-7.
    View in: PubMed
    Score: 0.146
  55. New insights into mechanisms of action of carvedilol treatment in chronic heart failure patients--a matter of time for contractility. J Card Fail. 2012 Mar; 18(3):183-93.
    View in: PubMed
    Score: 0.142
  56. Recurrent low-level troponin I elevation is a worse prognostic indicator than occasional injury pattern in patients hospitalized with heart failure. Int J Cardiol. 2013 Jun 20; 166(2):394-8.
    View in: PubMed
    Score: 0.141
  57. Guiding left ventricular lead positioning and refining ability to predict response and nonresponse to cardiac resynchronization therapy using dP/dt max: killing 3 birds with 1 high-fidelity wire? J Am Coll Cardiol. 2011 Sep 06; 58(11):1137-9.
    View in: PubMed
    Score: 0.139
  58. Association of systolic blood pressure with mortality in patients with heart failure with reduced ejection fraction: a complex relationship. Am Heart J. 2011 Mar; 161(3):567-73.
    View in: PubMed
    Score: 0.134
  59. Biomarkers of inflammation in heart failure. Heart Fail Rev. 2010 Jul; 15(4):331-41.
    View in: PubMed
    Score: 0.128
  60. Digoxin treatment in heart failure--unveiling risk by cluster analysis of DIG data. Int J Cardiol. 2011 Aug 04; 150(3):264-9.
    View in: PubMed
    Score: 0.127
  61. Comparison of patients with heart failure and preserved left ventricular ejection fraction among those with versus without diabetes mellitus. Am J Cardiol. 2010 Feb 01; 105(3):373-7.
    View in: PubMed
    Score: 0.123
  62. Impact of alpha 1-adrenergic antagonist use for benign prostatic hypertrophy on outcomes in patients with heart failure. Am J Cardiol. 2009 Jul 15; 104(2):270-5.
    View in: PubMed
    Score: 0.120
  63. Reduction in BNP levels with treatment of decompensated heart failure and future clinical events. J Card Fail. 2009 May; 15(4):293-9.
    View in: PubMed
    Score: 0.115
  64. Ambulatory Stage C2D Heart Failure Definitions and Current Therapeutic Approaches: JACC: Heart Failure Position Statement. JACC Heart Fail. 2026 Jun; 14(6):103101.
    View in: PubMed
    Score: 0.096
  65. Kidney disease and heart failure: recent advances and current challenges: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2026 Jun; 109(6):1095-1113.
    View in: PubMed
    Score: 0.095
  66. Kidney Disease and Heart Failure: Recent Advances and Current Challenges: Conclusions From a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. JACC Heart Fail. 2026 Apr; 14(4):102943.
    View in: PubMed
    Score: 0.095
  67. Ten years real-world experience with sacubitril/valsartan in patients with heart failure with reduced ejection fraction. ESC Heart Fail. 2026 Mar 03; 13(2).
    View in: PubMed
    Score: 0.095
  68. Comparison of morbidity in women versus men with heart failure and preserved ejection fraction. Am J Cardiol. 2006 Apr 15; 97(8):1228-31.
    View in: PubMed
    Score: 0.095
  69. Integrated Health Technologies in Heart Failure: A Scientific Statement From the Heart Failure Society of America and the American Association of Heart Failure Nurses. J Card Fail. 2026 Mar; 32(3):619-632.
    View in: PubMed
    Score: 0.094
  70. Integrated Health Technologies in Heart Failure: A Scientific Statement From the Heart Failure Society of America and the American Association of Heart Failure Nurses. Heart Lung. 2026 May-Jun; 77:102681.
    View in: PubMed
    Score: 0.094
  71. Subgroups and Special Populations in Heart Failure Clinical Trials: Insights From the HFC-ARC Expert Consensus Panel. JACC Heart Fail. 2026 Apr; 14(4):102775.
    View in: PubMed
    Score: 0.094
  72. Obesity as a prognostic factor in chronic symptomatic heart failure. Am Heart J. 2005 Dec; 150(6):1233-9.
    View in: PubMed
    Score: 0.093
  73. Pharmacological treatment for patients with obesity and heart failure: Focus on glucagon-like peptide-1 receptor agonists. European Journal of Heart Failure expert consensus document. Eur J Heart Fail. 2025 Nov; 27(11):2465-2479.
    View in: PubMed
    Score: 0.093
  74. Urinary markers in heart failure?-?types, timing and thresholds. European Journal of Heart Failure expert consensus document. Eur J Heart Fail. 2025 Nov; 27(11):2372-2396.
    View in: PubMed
    Score: 0.093
  75. Prevention of heart failure after acute myocardial infarction. Lancet. 2025 Sep 13; 406(10508):1154-1170.
    View in: PubMed
    Score: 0.091
  76. Management of patients with heart failure at high risk of hyperkalaemia: The CARE-HK in HF registry. Eur J Heart Fail. 2025 Nov; 27(11):2410-2421.
    View in: PubMed
    Score: 0.091
  77. Timing of Cardiac Resynchronization Therapy Following Stable Medical Therapy in Patients With Heart Failure. JACC Heart Fail. 2025 Oct; 13(10):102515.
    View in: PubMed
    Score: 0.090
  78. Clinical management and therapeutic optimization of patients with heart failure with reduced ejection fraction and low blood pressure. A clinical consensus statement of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2025 Apr; 27(4):707-722.
    View in: PubMed
    Score: 0.088
  79. Assessment of frailty in patients with heart failure: A new Heart Failure Frailty Score developed by Delphi consensus. ESC Heart Fail. 2025 Jun; 12(3):1818-1831.
    View in: PubMed
    Score: 0.088
  80. Revisiting ICD Therapy for Primary Prevention in Patients With Heart?Failure and Reduced Ejection Fraction. JACC Heart Fail. 2025 01; 13(1):1-13.
    View in: PubMed
    Score: 0.087
  81. Machine learning in the prevention of heart failure. Heart Fail Rev. 2025 Jan; 30(1):117-129.
    View in: PubMed
    Score: 0.086
  82. Cardiovascular and Renal Treatment in Heart Failure Patients With Hyperkalemia or High Risk of Hyperkalemia: Rationale and Design of the CARE-HK in HF Registry. J Card Fail. 2025 06; 31(6):881-891.
    View in: PubMed
    Score: 0.085
  83. 2024 Update to the 2020 ACC/AHA Clinical Performance and Quality Measures for Adults With Heart Failure: A Report of the American Heart Association/American College of Cardiology Joint Committee on Performance Measures. Circ Cardiovasc Qual Outcomes. 2024 Sep; 17(9):e000132.
    View in: PubMed
    Score: 0.085
  84. 2024 Update to the 2020 ACC/AHA Clinical Performance and Quality Measures for Adults With Heart Failure: A Report of the American Heart Association/American College of Cardiology Joint Committee on Performance Measures. J Am Coll Cardiol. 2024 Sep 17; 84(12):1123-1143.
    View in: PubMed
    Score: 0.085
  85. 2024 ACC Expert Consensus Decision Pathway on Clinical Assessment, Management, and Trajectory of Patients Hospitalized With Heart?Failure Focused Update: A Report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol. 2024 Sep 24; 84(13):1241-1267.
    View in: PubMed
    Score: 0.085
  86. Artificial intelligence predictive analytics in heart failure: results of the pilot phase of a pragmatic randomized clinical trial. J Am Med Inform Assoc. 2024 04 03; 31(4):919-928.
    View in: PubMed
    Score: 0.083
  87. Contemporary American and?European?Guidelines for Heart Failure Management: JACC: Heart?Failure Guideline Comparison. JACC Heart Fail. 2024 May; 12(5):810-825.
    View in: PubMed
    Score: 0.083
  88. Left Ventricular Ejection Fraction and the Future of Heart?Failure Phenotyping. JACC Heart Fail. 2024 Mar; 12(3):451-460.
    View in: PubMed
    Score: 0.081
  89. Standardized Definitions for Evaluation of?Acute Decompensated Heart?Failure?Therapies: HF-ARC Expert Panel Paper. JACC Heart Fail. 2024 01; 12(1):1-15.
    View in: PubMed
    Score: 0.081
  90. Incidence, risk assessment and prevention of sudden cardiac death in cardiomyopathies. Eur J Heart Fail. 2023 12; 25(12):2144-2163.
    View in: PubMed
    Score: 0.081
  91. Practical algorithms for early diagnosis of heart failure and heart stress using NT-proBNP: A clinical consensus statement from the Heart Failure Association of the ESC. Eur J Heart Fail. 2023 11; 25(11):1891-1898.
    View in: PubMed
    Score: 0.080
  92. State-of-the-art document on optimal contemporary management of cardiomyopathies. Eur J Heart Fail. 2023 11; 25(11):1899-1922.
    View in: PubMed
    Score: 0.080
  93. A scoping review of heart failure transitional care quality indicators and outcomes for use in clinical care and research. Eur J Heart Fail. 2023 10; 25(10):1842-1848.
    View in: PubMed
    Score: 0.080
  94. Utilization Rates of SGLT2 Inhibitors Among Patients With Type 2 Diabetes, Heart Failure, and Atherosclerotic Cardiovascular Disease: Insights From the Department of Veterans Affairs. JACC Heart Fail. 2023 08; 11(8 Pt 1):933-942.
    View in: PubMed
    Score: 0.078
  95. Management of Heart Failure-Related Cardiogenic Shock: Practical Guidance for Clinicians. JACC Heart Fail. 2023 07; 11(7):845-851.
    View in: PubMed
    Score: 0.078
  96. Optimizing outcomes in heart failure: 2022 and beyond. ESC Heart Fail. 2023 08; 10(4):2159-2169.
    View in: PubMed
    Score: 0.078
  97. Use of biomarkers in the management of heart failure: are we there yet? Circulation. 2003 Mar 11; 107(9):1231-3.
    View in: PubMed
    Score: 0.077
  98. Association of Long-term Change in N-Terminal Pro-B-Type Natriuretic Peptide With Incident Heart Failure and Death. JAMA Cardiol. 2023 03 01; 8(3):222-230.
    View in: PubMed
    Score: 0.077
  99. Misconceptions and Facts about Heart Failure with Reduced Ejection Fraction. Am J Med. 2023 05; 136(5):422-431.
    View in: PubMed
    Score: 0.076
  100. Reclassification of Pre-Heart Failure Stages Using Cardiac Biomarkers: The ARIC Study. JACC Heart Fail. 2023 04; 11(4):440-450.
    View in: PubMed
    Score: 0.076
  101. Complications of inappropriate use of spironolactone in heart failure: when an old medicine spirals out of new guidelines. J Am Coll Cardiol. 2003 Jan 15; 41(2):211-4.
    View in: PubMed
    Score: 0.076
  102. Complementary and Alternative Medicines in the Management of Heart Failure: A Scientific Statement From the American Heart Association. Circulation. 2023 01 10; 147(2):e4-e30.
    View in: PubMed
    Score: 0.076
  103. Preclinical and clinical assessment of the safety and potential efficacy of thalidomide in heart failure. J Card Fail. 2002 Oct; 8(5):306-14.
    View in: PubMed
    Score: 0.075
  104. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022 05 03; 145(18):e895-e1032.
    View in: PubMed
    Score: 0.072
  105. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022 05 03; 145(18):e876-e894.
    View in: PubMed
    Score: 0.072
  106. 2022 American College of Cardiology/American Heart Association/Heart Failure Society of America Guideline for the Management of Heart Failure: Executive Summary. J Card Fail. 2022 05; 28(5):810-830.
    View in: PubMed
    Score: 0.072
  107. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2022 05 03; 79(17):e263-e421.
    View in: PubMed
    Score: 0.072
  108. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2022 05 03; 79(17):1757-1780.
    View in: PubMed
    Score: 0.072
  109. An Updated Review on the Role of Non-dihydropyridine Calcium Channel Blockers and Beta-blockers in Atrial Fibrillation and Acute Decompensated Heart Failure: Evidence and Gaps. Cardiovasc Drugs Ther. 2023 12; 37(6):1205-1223.
    View in: PubMed
    Score: 0.072
  110. The year in cardiovascular medicine 2021: heart failure and cardiomyopathies. Eur Heart J. 2022 Feb 03; 43(5):367-376.
    View in: PubMed
    Score: 0.071
  111. Sex Differences in Heart Failure. J Card Fail. 2022 03; 28(3):477-498.
    View in: PubMed
    Score: 0.070
  112. Cardiac rehabilitation in heart failure: Indications for exercise training based on heart failure phenotype. Prog Cardiovasc Dis. 2022 Jan-Feb; 70:16-21.
    View in: PubMed
    Score: 0.070
  113. Public perception of heart failure on twitter: A sentiment analysis. Prog Cardiovasc Dis. 2021 Sep-Oct; 68:91-93.
    View in: PubMed
    Score: 0.070
  114. Patient Characteristics and Outcomes of Type 2 Myocardial Infarction During Heart Failure Hospitalizations in the United States. Am J Med. 2021 11; 134(11):1371-1379.e2.
    View in: PubMed
    Score: 0.068
  115. Heart Failure Association of the ESC, Heart Failure Society of America and Japanese Heart Failure Society Position statement on endomyocardial biopsy. Eur J Heart Fail. 2021 06; 23(6):854-871.
    View in: PubMed
    Score: 0.068
  116. Heart Failure Association, Heart Failure Society of America, and Japanese Heart Failure Society Position Statement on Endomyocardial Biopsy. J Card Fail. 2021 07; 27(7):727-743.
    View in: PubMed
    Score: 0.068
  117. 2021: The American Association for Thoracic Surgery Expert Consensus Document: Coronary artery bypass grafting in patients with ischemic cardiomyopathy and heart failure. J Thorac Cardiovasc Surg. 2021 Sep; 162(3):829-850.e1.
    View in: PubMed
    Score: 0.068
  118. The role of anti-cytokine therapy in the failing heart. Heart Fail Rev. 2001 Mar; 6(2):143-51.
    View in: PubMed
    Score: 0.067
  119. Activation of cytokines as a mechanism of disease progression in heart failure. Ann Rheum Dis. 2000 Nov; 59 Suppl 1:i90-3.
    View in: PubMed
    Score: 0.065
  120. Conducting clinical trials in heart failure during (and after) the COVID-19 pandemic: an Expert Consensus Position Paper from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC). Eur Heart J. 2020 06 07; 41(22):2109-2117.
    View in: PubMed
    Score: 0.064
  121. Endpoints in Heart?Failure Drug?Development: History and Future. JACC Heart Fail. 2020 06; 8(6):429-440.
    View in: PubMed
    Score: 0.063
  122. Evaluation for Heart Transplantation and?LVAD Implantation: JACC Council Perspectives. J Am Coll Cardiol. 2020 03 31; 75(12):1471-1487.
    View in: PubMed
    Score: 0.063
  123. Continuous Wearable Monitoring Analytics Predict Heart Failure Hospitalization: The LINK-HF Multicenter Study. Circ Heart Fail. 2020 03; 13(3):e006513.
    View in: PubMed
    Score: 0.062
  124. 2019 ACC Expert Consensus Decision Pathway on Risk Assessment, Management, and Clinical Trajectory of Patients Hospitalized With Heart?Failure: A Report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol. 2019 10 15; 74(15):1966-2011.
    View in: PubMed
    Score: 0.060
  125. Heart Failure Site-Based Research in?the United States: Results of the Heart Failure Society of America Research?Network Survey. JACC Heart Fail. 2019 05; 7(5):431-438.
    View in: PubMed
    Score: 0.059
  126. Lifestyle Modifications for Preventing?and Treating Heart?Failure. J Am Coll Cardiol. 2018 11 06; 72(19):2391-2405.
    View in: PubMed
    Score: 0.057
  127. Evaluation and Management of Right-Sided Heart Failure: A Scientific Statement From the American Heart Association. Circulation. 2018 05 15; 137(20):e578-e622.
    View in: PubMed
    Score: 0.055
  128. 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. Circulation. 2017 08 08; 136(6):e137-e161.
    View in: PubMed
    Score: 0.051
  129. 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the?Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. J Am Coll Cardiol. 2017 08 08; 70(6):776-803.
    View in: PubMed
    Score: 0.051
  130. 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the?Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. J Card Fail. 2017 08; 23(8):628-651.
    View in: PubMed
    Score: 0.051
  131. Role of Biomarkers for the Prevention, Assessment, and Management of Heart Failure: A Scientific Statement From the American Heart Association. Circulation. 2017 May 30; 135(22):e1054-e1091.
    View in: PubMed
    Score: 0.051
  132. BNP and obesity in acute decompensated heart failure with preserved vs. reduced ejection fraction: The Atherosclerosis Risk in Communities Surveillance Study. Int J Cardiol. 2017 Apr 15; 233:61-66.
    View in: PubMed
    Score: 0.050
  133. Myocardial Injury, Obesity, and the Obesity Paradox: The ARIC Study. JACC Heart Fail. 2017 01; 5(1):56-63.
    View in: PubMed
    Score: 0.050
  134. Association between high-sensitivity troponin T and cardiovascular risk in individuals with and without metabolic syndrome: The ARIC study. Eur J Prev Cardiol. 2017 04; 24(6):628-638.
    View in: PubMed
    Score: 0.050
  135. 2016 ACC/AHA/HFSA Focused Update on New Pharmacological Therapy for Heart Failure: An Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. Circulation. 2016 09 27; 134(13):e282-93.
    View in: PubMed
    Score: 0.048
  136. 2016 ACC/AHA/HFSA Focused Update on New Pharmacological Therapy for Heart Failure: An Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task?Force?on?Clinical Practice Guidelines and the Heart Failure Society of America. J Am Coll Cardiol. 2016 09 27; 68(13):1476-1488.
    View in: PubMed
    Score: 0.048
  137. Diagnosis and management of acute heart failure. Anatol J Cardiol. 2015 Nov; 15(11):860-89.
    View in: PubMed
    Score: 0.046
  138. Pre-morbid body mass index and mortality after incident heart failure: the ARIC Study. J Am Coll Cardiol. 2014 Dec 30; 64(25):2743-9.
    View in: PubMed
    Score: 0.044
  139. Peripartum cardiomyopathy: current state of knowledge, new developments and future directions. Curr Cardiol Rev. 2014 Nov; 10(4):317-26.
    View in: PubMed
    Score: 0.043
  140. Prognostic significance of hyponatremia among ambulatory patients with heart failure and preserved and reduced ejection fractions. Am J Cardiol. 2014 Jun 01; 113(11):1834-8.
    View in: PubMed
    Score: 0.041
  141. Cardiovascular function and treatment in ?-thalassemia major: a consensus statement from the American Heart Association. Circulation. 2013 Jul 16; 128(3):281-308.
    View in: PubMed
    Score: 0.039
  142. 2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation. 2013 Oct 15; 128(16):1810-52.
    View in: PubMed
    Score: 0.039
  143. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation. 2013 Oct 15; 128(16):e240-327.
    View in: PubMed
    Score: 0.039
  144. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013 Oct 15; 62(16):e147-239.
    View in: PubMed
    Score: 0.039
  145. Prevalence, morbidity, and mortality of heart failure-related hospitalizations in children in the United States: a population-based study. J Card Fail. 2012 Jun; 18(6):459-70.
    View in: PubMed
    Score: 0.036
  146. Impact of noncardiac comorbidities on morbidity and mortality in a predominantly male population with heart failure and preserved versus reduced ejection fraction. J Am Coll Cardiol. 2012 Mar 13; 59(11):998-1005.
    View in: PubMed
    Score: 0.036
  147. Results of the Randomized Aldosterone Antagonism in Heart Failure with Preserved Ejection Fraction trial (RAAM-PEF). J Card Fail. 2011 Aug; 17(8):634-42.
    View in: PubMed
    Score: 0.034
  148. Central venous pressure and pulmonary capillary wedge pressure: fresh clinical perspectives from a new model of discordant and concordant heart failure. Tex Heart Inst J. 2011; 38(6):627-38.
    View in: PubMed
    Score: 0.033
  149. Trials on the effect of cardiac resynchronization on arterial blood pressure in patients with heart failure. Am J Cardiol. 2011 Feb 15; 107(4):561-8.
    View in: PubMed
    Score: 0.033
  150. Metformin use and mortality in ambulatory patients with diabetes and heart failure. Circ Heart Fail. 2011 Jan; 4(1):53-8.
    View in: PubMed
    Score: 0.033
  151. Relationship of hemoglobin A1C and mortality in heart failure patients with diabetes. J Am Coll Cardiol. 2009 Jul 28; 54(5):422-8.
    View in: PubMed
    Score: 0.030
  152. The metabolic syndrome and mortality in an ethnically diverse heart failure population. J Card Fail. 2008 Sep; 14(7):590-5.
    View in: PubMed
    Score: 0.028
  153. The impact of thiazolidinedione use on outcomes in ambulatory patients with diabetes mellitus and heart failure. J Am Coll Cardiol. 2007 Jul 03; 50(1):32-6.
    View in: PubMed
    Score: 0.026
  154. Effect of atrial overdrive pacing on obstructive sleep apnea in patients with systolic heart failure. Sleep Med. 2007 Jan; 8(1):31-6.
    View in: PubMed
    Score: 0.025
  155. Plasma matrix metalloproteinase and inhibitor profiles in patients with heart failure. J Card Fail. 2002 Dec; 8(6):390-8.
    View in: PubMed
    Score: 0.019
  156. End-stage cardiac failure in a morbidly obese patient treated by biliopancreatic diversion and cardiac transplantation. Obes Surg. 2002 Jun; 12(3):416-8.
    View in: PubMed
    Score: 0.018
  157. Tumor necrosis factor-alpha and myocardial remodeling in progression of heart failure: a current perspective. Cardiovasc Res. 2002 Mar; 53(4):822-30.
    View in: PubMed
    Score: 0.018
  158. New therapeutics for chronic heart failure. Annu Rev Med. 2002; 53:59-74.
    View in: PubMed
    Score: 0.018
  159. Hemodynamic effects of tezosentan, an intravenous dual endothelin receptor antagonist, in patients with class III to IV congestive heart failure. Circulation. 2001 Feb 20; 103(7):973-80.
    View in: PubMed
    Score: 0.017
  160. Experimental options in the treatment of heart failure: the role of cytokine antagonism. Heart Fail Monit. 2001; 1(4):114-21.
    View in: PubMed
    Score: 0.017
  161. Veterans Affairs Quality Enhancement Research Initiative in chronic heart failure. Med Care. 2000 Jun; 38(6 Suppl 1):I26-37.
    View in: PubMed
    Score: 0.016
  162. Cytokines in heart failure: pathogenetic mechanisms and potential treatment. Proc Assoc Am Physicians. 1999 Sep-Oct; 111(5):423-8.
    View in: PubMed
    Score: 0.015
  163. Safety and efficacy of a soluble P75 tumor necrosis factor receptor (Enbrel, etanercept) in patients with advanced heart failure. Circulation. 1999 Jun 29; 99(25):3224-6.
    View in: PubMed
    Score: 0.015
  164. An overview of tumor necrosis factor alpha and the failing human heart. Curr Opin Cardiol. 1999 May; 14(3):206-10.
    View in: PubMed
    Score: 0.015
  165. Cardiac remodeling as a consequence and cause of progressive heart failure. Clin Cardiol. 1998 Dec; 21(12 Suppl 1):I14-9.
    View in: PubMed
    Score: 0.014
  166. The role of cytokines in the failing human heart. Cardiol Clin. 1998 Nov; 16(4):645-56, viii.
    View in: PubMed
    Score: 0.014
  167. Maternal Obesity Affects Cardiac Remodeling and Recovery in Women with Peripartum Cardiomyopathy. Am J Perinatol. 2019 04; 36(5):476-483.
    View in: PubMed
    Score: 0.014
  168. Basic mechanisms in heart failure: the cytokine hypothesis. J Card Fail. 1996 Sep; 2(3):243-9.
    View in: PubMed
    Score: 0.012
  169. Circulating collagen biomarkers as indicators of disease severity in pulmonary arterial hypertension. JACC Heart Fail. 2014 Aug; 2(4):412-21.
    View in: PubMed
    Score: 0.011
  170. Third universal definition of myocardial infarction. J Am Coll Cardiol. 2012 Oct 16; 60(16):1581-98.
    View in: PubMed
    Score: 0.009
  171. Effect of the soluble TNF-antagonist etanercept on tumor necrosis factor bioactivity and stability. Clin Transl Sci. 2008 Sep; 1(2):142-5.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.